GLI1 and cancer: These results are consistent with previous findings showing that these two pathways could upregulate GLI1/GLI2 expression levels or transcriptional activity in other cancer types, including glioblastoma, melanoma, colon cancer, and pancreatic adenocarcinoma [213,214,215,216].